Skip to Content

Sclerosis, Volume 3, Issue 2

2025 June - 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

  • Review
  • Open Access
9,470 Views
32 Pages

Systemic sclerosis (SSc) is a multifaceted autoimmune disease in which the complex interplay of genetic predisposition and environmental factors triggers aberrant immune responses, ultimately leading to vasculopathy and fibrosis. This review offers a...

(This article belongs to the Special Issue Recent Advances in Understanding Systemic Sclerosis)
  • Systematic Review
  • Open Access
3,415 Views
18 Pages

Background/Objectives: Late-onset multiple sclerosis (LOMS), characterized by an onset of disease at ≥50 years, is a distinct subset of multiple sclerosis (MS) with unique clinical and demographic features. While environmental factors such as smok...

(This article belongs to the Special Issue Exploring Environmental Risk Factors for Disease Progression in Multiple Sclerosis and Amyotrophic Lateral Sclerosis)
  • Systematic Review
  • Open Access
3 Citations
3,706 Views
20 Pages

The Metabolomic View of Systemic Sclerosis—A Systematic Literature Review

  • Sebastian T. Jendrek,
  • Franziska Schmelter,
  • Christian Sina,
  • Ulrich L. Günther and
  • Gabriela Riemekasten

The mortality risk in systemic sclerosis (SSc) is primarily determined by pulmonary involvement (interstitial lung disease (ILD), pulmonary fibrosis), pulmonary arterial hypertension (PAH), and cardiac involvement. With timely and intensive treatment...

(This article belongs to the Special Issue Recent Advances in Understanding Systemic Sclerosis)
  • Review
  • Open Access
8 Citations
11,461 Views
16 Pages

Background: Systemic sclerosis (SSc) is a rare connective tissue disease characterized by vasculopathy, autoimmunity, and fibrosis. Due to its low prevalence and heterogeneous clinical presentation, early diagnosis remains challenging, often delaying...

(This article belongs to the Special Issue Recent Advances in Understanding Systemic Sclerosis)
  • Review
  • Open Access
2 Citations
4,342 Views
13 Pages

MicroRNA as a Potential Biomarker for Amyotrophic Lateral Sclerosis (ALS)

  • José Augusto Nogueira-Machado,
  • Amanda Tábita da Silva Albanaz and
  • Fabiana Rocha-Silva

Background: Amyotrophic lateral sclerosis (ALS) is a rare, incurable, and fatal neurodegenerative disease that affects the muscles and results in paralysis. The onset and development of ALS involve complex interactions among metabolic signaling, gene...

  • Feature Paper
  • Review
  • Open Access
5 Citations
6,695 Views
19 Pages

Harnessing Artificial Intelligence for the Diagnosis, Treatment and Research of Multiple Sclerosis

  • Manisha S. Patil,
  • Linda Y. Lin,
  • Rachel K. Ford,
  • Elizaveta J. James and ,
  • Stella Morton,
  • Felix Marsh-Wakefield,
  • Simon Hawke and
  • Georges E. Grau
  • + 3 authors+ 0 author

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system affecting over 2.8 million people around the world. Artificial intelligence (AI) is becoming increasingly utilised in many areas, including patient care for MS. AI is revo...

  • Article
  • Open Access
2,184 Views
13 Pages

Introduction: Cognitive impairment (CI) is recognized as a very frequent feature of persons with multiple sclerosis (pwMSs). Multiple studies have demonstrated the effectiveness of cognitive rehabilitation (CR) in improving CI linked to cerebral func...

(This article belongs to the Special Issue Neuropsychiatric and Quality of Life (QoL) Aspects of Multiple Sclerosis, 2nd Edition)
  • Review
  • Open Access
2,480 Views
20 Pages

Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis

  • Katarzyna Wiszniewska,
  • Małgorzata Wilk,
  • Małgorzata Wiszniewska,
  • Joanna Poszwa and ,
  • Oliwia Szymanowicz,
  • Wojciech Kozubski and
  • Jolanta Dorszewska
  • + 2 authors+ 0 author

Multiple sclerosis (MS) is a chronic and incurable neurological disease of the central nervous system. Three main forms of the disease have been distinguished: relapsing–remitting form (RRMS), secondary progressive form (SPMS), and primary prog...

  • Opinion
  • Open Access
2,655 Views
9 Pages

Behavioral activation therapy (BAT) was initially developed to treat depression and was subsequently extended as a transdiagnostic therapy for other psychiatric and neurocognitive disorders. However, research on its impact in people with multiple scl...

(This article belongs to the Special Issue Neuropsychiatric and Quality of Life (QoL) Aspects of Multiple Sclerosis, 2nd Edition)
  • Review
  • Open Access
2 Citations
6,184 Views
18 Pages

Biomarkers in Systemic Sclerosis

  • Claudio Karsulovic and
  • Lia Hojman

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vasculopathy, immune dysregulation, and progressive fibrosis affecting the skin and internal organs. Pulmonary complications, including interstitial lung disease (ILD) and pulm...

(This article belongs to the Special Issue Recent Advances in Understanding Systemic Sclerosis)
  • Feature Paper
  • Article
  • Open Access
2 Citations
3,540 Views
15 Pages

Background/Objectives: Health locus of control (LOC) refers to one’s perceptions of who or what controls one’s health. Recent evidence has found that chance LOC (CLOC) is associated with improved quality of life (QoL) in multiple sclerosi...

(This article belongs to the Special Issue Neuropsychiatric and Quality of Life (QoL) Aspects of Multiple Sclerosis, 2nd Edition)
  • Communication
  • Open Access
1,750 Views
11 Pages

Biomarker Identification in Patients with Multiple Sclerosis Treated with Autologous Hematopoietic Stem Cell Transplantation

  • Moisés Manuel Gallardo-Pérez,
  • Alejandro Ruiz-Argüelles,
  • Guillermo José Ruiz-Argüelles,
  • Virginia Reyes-Núñez and ,
  • Silvia Soto-Olvera and
  • Solón Javier Garcés-Eisele
  • + 1 author+ 0 author

Introduction: Approximately 80% of individuals with multiple sclerosis (MS) have a positive response to autologous hematopoietic stem cell transplantation (aHSCT). Markers that may predict the transplant outcome are necessary. The objective of this w...

XFacebookLinkedIn
Sclerosis - ISSN 2813-3064